Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 14, 2026
HSV and cancer: What patients should know
Cancer treatments can weaken immunity and trigger herpes simplex reactivation, but patients can take protective steps
Fred Hutch researchers look at longevity in older women, metabolic signatures of vaginitis
Two prestigious R01 NIH grants awarded to Drs. Alex Reiner, Sujatha Srinivasan
Recurring escape routes reveal patterns in HIV evolution
From the Cohn Lab, Vaccine and Infectious Disease Division
A structural blueprint for protection against Dengue and Zika
From the Pancera Lab, Vaccine and Infectious Diseases Division
Nextstrain virus-tracking platform moves into new phase
Dr. JT McCrone will oversee Gates Foundation-funded efforts to further empower users
Fred Hutch Cancer Center announces 2026 Evergreen Fund awardees
Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential
CAR-T cell patients have depleted antibody immunity. Vaccination can restore it for some
From the Joshua Hill Lab, Vaccine and Infectious Disease and Clinical Research Divisions
Mail-in immune monitoring brings clinical trials closer to home
From the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
PrEP-ping T cells for HIV exposure
From the Lund Lab, Vaccine and Infectious Disease Division
Dr. Hans-Peter Kiem receives ASGCT mentorship award
Fred Hutch gene therapy expert views mentorship as a lifelong commitment
Answering WHO’s call with a new way to track how well we’re fighting the flu
Fred Hutch researchers’ immunity data informs global vaccine updates
Fred Hutch researchers receive prestigious R01 awards
NIH-funded awards will support multi-year investigations into HIV reservoirs, biomarkers of vaccine efficacy and how PrEP influences antibody pharmacokinetics
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
Taming viral threats after lifesaving transplants
From the Boeckh Lab, Vaccine and Infectious Disease Division